The global infertility treatment market is set for substantial growth, with projected sales reaching USD 1,899.8 million in 2024 and an estimated value of USD 3,843.3 million by 2034. This robust expansion reflects a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2024 to 2034.
The market saw significant revenue generation of USD 1,770.6 million in 2023 and is expected to exhibit a year-over-year growth of 7.4% in 2024. This upward trajectory underscores a heightened demand for effective infertility treatments driven by evolving societal factors and medical advancements.
Infertility, which impacts both partners due to a range of conditions, requires precise and individualized treatment approaches. The complexity of diagnosing and treating infertility involves various specialized devices and instruments, and treatment methods may include surgery, medication, or assisted reproductive technologies (ART).
Several factors contribute to the rising demand for infertility treatments. Changing lifestyles, delayed marriages, and environmental influences have led to an increase in infertility cases. Additionally, medical conditions such as polycystic ovary syndrome (PCOS) and other reproductive disorders are significant drivers of market growth, further amplifying the need for effective treatment solutions.
“The significant growth forecast for the infertility treatment market reflects both the increasing prevalence of infertility and the advancements in treatment technologies,” said FMI. “As we continue to innovate and expand treatment options, we are committed to addressing the diverse needs of individuals and couples seeking to overcome infertility challenges.”
The global infertility treatment market is on an impressive upward trajectory, driven by a combination of lifestyle changes, medical conditions, and technological advancements. As the industry evolves, it is expected to continue delivering impactful solutions for those affected by infertility.
Key Takeaways: Infertility Treatment Market
- The global infertility treatment market is expected to grow significantly over the next decade, driven by factors such as increasing infertility rates and advancements in medical technology.
- The market is projected to reach USD 3,843.3 million by 2034, up from USD 1,899.8 million in 2024.
- The market is anticipated to grow at a CAGR of 7.3% during the forecast period.
- The German market holds the highest market share in Europe and is expected to grow at a CAGR of 2.3%.
- The US market is also projected to grow at a CAGR of 2.3%.
- China is the dominant player in the East Asia market and is expected to grow at a CAGR of 7.3%.
- Media & consumables are the largest segment, accounting for 46.6% of the global market.
- Assisted reproductive technology is the leading procedure, with a market share of 31.7%.
Heightened Demand for Market Data: Our Full Report Provides Extensive Trend Analysis!
Competitive Landscape:
The infertility treatment market is characterized by a high degree of fragmentation, with numerous manufacturers around the globe striving to develop innovative solutions to meet evolving customer needs.
Leading manufacturers in the infertility treatment sector are focusing on international expansion to boost revenue and extend their market reach into developing countries. This growth strategy often involves acquiring regional competitors and employing key tactics such as agreements, product launches, research sponsorships, and strategic collaborations to enhance product sales and solidify their market presence.
Notable players in the infertility treatment market include:
- Thermo Fisher Scientific Inc.: A U.S.-based multinational medical technology company, Thermo Fisher offers a range of products including Nunc™ IVF Dishes, untreated dishes, electron microscopes, lab plasticware and supplies, lab centrifuges, mass spectrometers, and next-generation sequencers.
- Cook Group Incorporated: An American medical devices company, Cook Group provides medical devices for specialties such as gastroenterology, interventional cardiology, interventional radiology, vascular surgery, and laboratory instruments.
- CooperSurgical Inc.: A global medical device manufacturer, CooperSurgical offers products like VitriFit™ Vitrification Carrier, VitriGuard™ Carrier, HBA® Assay, Standard Count Disposable Analysis Chamber, and Makler® Chamber.
Key Players of Infertility Treatment Industry:
- Thermo Fisher Scientific
- Cook Group
- CooperSurgical Inc.
- AB Scientific Ltd.
- Vitrolife
- IVFtech APS
- Hamilton Thorne Ltd.
- Esco Micro Pte Ltd.
- Genea Biomedx Ltd.
- FUJIFILM Irvine Scientific
- Baker Company INC.
Key Segments of Infertility Treatment Industry:
By Product:
In terms of product, the industry is divided into equipment (microscopes, imaging systems, sperm analyser systems, ovum aspiration pumps, micromanipulator systems, incubators, gas analyzers, laser systems, cryosystems, and sperm separation devices), media & consumables and accessories
By Procedure:
In terms of procedure, the industry is divided into assisted reproductive technology [in vitro fertilization (intracytoplasmic morphologically selected sperm injection and gamete donation), intracytoplasmic sperm injection, and surrogacy], artificial insemination (intrauterine insemination, intracervical insemination and intratubal insemination), fertility surgeries [laparoscopy, hysteroscopy, varicocelectomy, laparotomy, tubal ligation reversal, microsurgical reconstruction (vasovasostomy and vasoepididymostomy)] and other infertility treatment procedures
By Patient Type:
In terms of patient type, the industry is segregated into female infertility treatment and male infertility treatment.
By End User:
In terms of end user, the industry is segregated into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes
By Region:
Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube